Old Web
Fr517 USE OF USTEKINUMAB AND RISK OF NEW OR RECURRENT CANCERS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND PRIOR MALIGNANCY
2021
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI